35303-76-5 | 4-(2-Aminoethyl)benzenesulfonamide

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$8.00	$5.00
10g	98%	in stock	$10.00	$7.00
25g	98%	in stock	$12.00	$8.00

Description

• Catalog Number: AB49296
• Chemical Name: 4-(2-Aminoethyl)benzenesulfonamide
• CAS Number: 35303-76-5
• Molecular Formula: C8H12N2O2S
• Molecular Weight: 200.2581
• MDL Number: MFCD00010301
• SMILES: NCCc1ccc(cc1)S(=O)(=O)N

Computed Properties

• Complexity: 237
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 13
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• XLogP3: -0.2

Literature

• Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.

  Journal of medicinal chemistry 20120412

• Design and synthesis of thiourea compounds that inhibit transmembrane anchored carbonic anhydrases.

  Bioorganic & medicinal chemistry 20120401

• Mutation of active site residues Asn67 to Ile, Gln92 to Val and Leu204 to Ser in human carbonic anhydrase II: influences on the catalytic activity and affinity for inhibitors.

  Bioorganic & medicinal chemistry 20120401

• Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.

  Bioorganic & medicinal chemistry 20120215

• Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.

  Bioorganic & medicinal chemistry 20110815

• Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.

  Acta pharmacologica Sinica 20110701

• A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.

  Bioorganic & medicinal chemistry 20110201

• Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.

  Bioorganic & medicinal chemistry letters 20110115

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Mutation of Phe91 to Asn in human carbonic anhydrase I unexpectedly enhanced both catalytic activity and affinity for sulfonamide inhibitors.

  Bioorganic & medicinal chemistry 20100801

• Low noise detection of biomolecular interactions with signal-locking surface plasmon resonance.

  Analytical chemistry 20100715

• Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia.

  Nuclear medicine and biology 20100701

• 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.

  Bioorganic & medicinal chemistry letters 20100515

• Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.

  Journal of medicinal chemistry 20100311

• Probing protein binding spectra with Fourier microfluidics.

  Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20100101

• Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.

  Bioorganic & medicinal chemistry letters 20091201

• 4-{2-[(5-Bromo-2-hydroxy-benzyl-idene)amino]eth-yl}benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20091001

• Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.

  Bioorganic & medicinal chemistry letters 20090901

• Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.

  Bioorganic & medicinal chemistry 20090715

• Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.

  Bioorganic & medicinal chemistry 20090701

• Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.

  Journal of medicinal chemistry 20090514

• Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.

  Journal of medicinal chemistry 20090423

• Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.

  Journal of enzyme inhibition and medicinal chemistry 20090401

• Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.

  Bioorganic & medicinal chemistry 20090201

• LC and LC-MS study on establishment of degradation pathway of glipizide under forced decomposition conditions.

  Journal of chromatographic science 20080701

• 4-{2-[(5-Chloro-2-hydroxy-benzyl-idene)amino]eth-yl}benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20080401

• The alpha-carbonic anhydrase from the malaria parasite and its inhibition.

  Current pharmaceutical design 20080101

• Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.

  Bioorganic & medicinal chemistry 20071201

• Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.

  Bioorganic & medicinal chemistry letters 20070701

• Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.

  Journal of medicinal chemistry 20070125

• Malarial parasite carbonic anhydrase and its inhibitors.

  Current topics in medicinal chemistry 20070101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.

  Bioorganic & medicinal chemistry letters 20060415

• QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.

  Bioorganic & medicinal chemistry letters 20060401

• Antibacterial, antifungal and cytotoxic properties of some sulfonamide-derived chromones.

  Journal of enzyme inhibition and medicinal chemistry 20060401

• Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.

  Journal of medicinal chemistry 20060323

• Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.

  Journal of medicinal chemistry 20051201

• Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry 20051115

• Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.

  Bioorganic & medicinal chemistry letters 20051101

• Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.

  Bioorganic & medicinal chemistry letters 20050901

• Carbonic anhydrase inhibitors. Inhibition of red blood cell ostrich (Struthio camelus) carbonic anhydrase with a series of aromatic and heterocyclic sulfonamides.

  Journal of enzyme inhibition and medicinal chemistry 20050801

• Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.

  Journal of medicinal chemistry 20050728

• Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.

  Bioorganic & medicinal chemistry letters 20050615

• Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.

  Bioorganic & medicinal chemistry letters 20050615

• Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.

  Bioorganic & medicinal chemistry letters 20050502

• Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.

  Bioorganic & medicinal chemistry letters 20041220

• Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.

  Bioorganic & medicinal chemistry letters 20041115

• Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.

  Bioorganic & medicinal chemistry letters 20041101

• Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.

  Bioorganic & medicinal chemistry letters 20040716

• Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20040621

• Carbonic anhydrase inhibitors: Schiff's bases of aromatic and heterocyclic sulfonamides and their metal complexes.

  Journal of enzyme inhibition and medicinal chemistry 20040601

• Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.

  Journal of medicinal chemistry 20040226

• Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.

  Bioorganic & medicinal chemistry letters 20040223

• Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamide-two heads are better than one?

  Bioorganic & medicinal chemistry letters 20030818

• Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20030324

• A simple LC method with UV detection for the analysis of creatine and creatinine and its application to several creatine formulations.

  Journal of pharmaceutical and biomedical analysis 20020731

• Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.

  Journal of medicinal chemistry 20020328

• Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.

  Bioorganic & medicinal chemistry letters 20010226